Kopp Family Office, LLC - Q4 2019 holdings

$157 Million is the total value of Kopp Family Office, LLC's 5 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was - .

 Value Shares↓ Weighting
NEO NewNeoGenomics Inc$141,705,0004,844,625
+100.0%
90.06%
RTIX NewRTI Surgical Inc.$10,165,0003,709,829
+100.0%
6.46%
FIVN NewFive9, Inc.$1,872,00028,550
+100.0%
1.19%
XENT NewIntersect ENT Inc.$1,868,00075,000
+100.0%
1.19%
VCEL NewVericel Corporation$1,737,00099,800
+100.0%
1.10%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NeoGenomics Inc.16Q3 202390.1%
Vericel Corporation16Q3 202314.5%
Five9, Inc.16Q3 202311.2%
ISHARES TR13Q3 202316.7%
ISHARES TR13Q3 202310.6%
ISHARES TR13Q3 20230.1%
ISHARES TR13Q3 20230.1%
ISHARES TR13Q3 20230.0%
ISHARES TR13Q3 20230.0%
ISHARES TR13Q3 20230.0%

View Kopp Family Office, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Kopp Family Office, LLC Q4 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
RTI Surgical Holdings, Inc.July 07, 2020? ?
NEOGENOMICS INCJanuary 07, 20204,844,6254.6%
OCLARO, INC.January 04, 2019? ?
SUPERCONDUCTOR TECHNOLOGIES INCOctober 05, 2018? ?

View Kopp Family Office, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-13
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-16
13F-HR2022-05-16
13F-HR2022-02-15
13F-HR2021-11-16

View Kopp Family Office, LLC's complete filings history.

Compare quarters

Export Kopp Family Office, LLC's holdings